1,2
We previously demonstrated that cardiac-specific overexpression of a constitutively active mutant of Akt (E40K-Akt) induces not only a physiological type of hypertrophy but also improvements in cardiac function by increasing L-type Ca 2 þ current and sarcoplasmic reticulum pump (SERCA) activity. 3 Accordingly, others found that with knockout of Akt-1 4 or overexpression of a dominant-negative PI3Ka mutant, 5 the physiological myocardial adaptations and hemodynamic improvements consequent to physical stress were prevented.
Induction of pressure overload through transverse aortic constriction (TAC) is an established technique that permits the study of the effects of gene overexpression or knockout in mice undergoing heart failure. Models of overexpression of Akt in CMCs present with significant phenotypic variability (reviewed by Catalucci et al. ). Constitutive or long-term overexpression of a myristilated (myr) form of Akt in CMCs were associated with negative effects on inotropism, either inducing heart failure or worsening cardiac function. 2 The negative effects of myr-Akt on cardiac function were reverted by expression of a constitutively active form of PI3Ka. 6 In contrast, cardiac-specific overexpression of myr-Akt improved cardiac function in the short-term: 2 here, Akt overexpression was accompanied by increased angiogenesis and VEGF protein expression. 2 Another interesting model of Akt overexpression is represented by cardiac-specific overexpression of a nuclear form of Akt, characterized by increased resistance to apoptosis and improved cardiac function. 7 We therefore assessed the effects of cardiac-specific overexpression of the E40K-Akt mutant on cardiac function in the TAC model of heart failure. We found that Akt ameliorates cardiac function by decreasing apoptosis and fibrosis and improving angiogenesis. We quantified capillaries in histological sections of hearts stained with FITC-conjugated lectin 8 ( Figure 1d , top). Under basal conditions, vascularization of Tg mouse myocardium was 1.8070.15 capillaries/CMC as compared to 1.1570.18 capillaries/CMC in WT controls (Figure 1d , bottom). One week after TAC, capillary density increased significantly in the myocardium of WT mice (1.5270.06 capillaries/CMC), thus accompanying the adaptive hypertrophic response. Longterm exposure (8 weeks) to pressure overload did not induce any further increase of capillaries/CMC. In Tg mice, however, the baseline capillary/CMC ratio was greater than that found in WT mice, and did not change significantly, neither during the first week of banding nor after 8 weeks.
As VEGF correlates with capillary density, 2,9 we studied VEGF levels. To this end, qRT-PCR was first used to investigate VEGF gene expression (Figure 1e, top) . Results show that in WT mice, VEGF mRNA was increased after 1 week of TAC and then returned to baseline at 8 weeks. No significant variation could be detected in Tg mice. Western blotting was then performed to investigate VEGF at the protein level (Figure 1e, bottom) . In WT mice, VEGF increased significantly (nine-fold) 1 week after TAC, then dropped significantly (1.5-fold) from this level at 8 weeks. In contrast, levels were higher in Tg mice (seven-fold) than in WT controls, and did not change after TAC.
Apoptosis is considered an important event during the early phases of heart failure. 10 Consequently, we compared apoptosis in the myocardium of WT and Tg mice after TAC with TUNEL (Figure 1f, left) . Baseline levels of apoptotic cells are normally negligible in healthy myocardium; in fact, we found rare TUNEL-positive nuclei both in WT and in Tg mice (Figure 1f, right) . In WT mice, apoptotic events in the myocardium were increased after 1 week of TAC and greatly Letters to the Editor increased after 8 weeks: the TUNEL-positive nuclei were seen in clusters. In contrast, Tg mice seemed protected from apoptosis, as the number of TUNEL-positive nuclei increased only slightly after 1 week of TAC and remained at low levels thereafter. At 8 weeks, Tg mice had three-fold less apoptotic cells than their respective WT counterparts. Fibrosis is another feature of the response to TAC, and becomes evident in WT after 8 weeks. It was never encountered in Tg mice (Figure 1 Supplementary Information) .
Thus, the pro-hypertrophic and antiapoptotic effects of Akt are not mutually exclusive. In fact, while inducing hypertrophy, overexpression of the E40K-Akt mutant is capable of preventing apoptosis of cardiac myocytes during pressure overload. This effect may well depend on both nuclear and cytoplasmic Akt localization and phosphorylation of relative substrates. In fact, cytoplasmic substrates of Akt involved in improving cardiac function include, among others, FOXO3 transcription factor 11 which, upon phosphorylation, is prevented from entering the nucleus and activating transcription of genes involved in protein catabolism or mitochondrial proteins involved in survival. 12 The pro-angiogenic effect of Akt overexpression can account at least partly for its antiapoptotic effect during pressure overload hypertrophy: beside its angiogenic effect, VEGF is a potent antiapoptotic agent for CMCs in in vivo models of cardiomyopathies. In fact, replenishment of VEGF levels using naked DNA gene therapy via direct intramyocardial injection of plasmid DNA encoding VEGF (phVEGF165) induced increased capillary density and decreased CMC apoptosis. 13 Absence of the upstream Akt activator PDK-1 in cardiac myocytes dramatically decreases the ability of CMCs to cope with hypoxia.
14 More recently, the absence of Akt1 in myocardial tissue was associated with worsening of cardiac function during pressure overload stress. 4 These two reports strongly suggest that Akt is necessary for preventing cellular damage also during increased workload.
Results of our as well as of other groups suggest that both nuclear and cytoplasmic localization are critical for Akt's antiapoptotic effects. The anti-hypertrophic effects of nuclear Akt were suggested to be dependent on gene expression of ANP, 15 which, upon an autocrine-paracrine effect, stimulates cGMP production and downstream signal transduction activation, leading to hypertrophy prevention. Such an effect seems also to account for the anti-hypertrophic effect of 17-b-estradiol, which also activates Akt, leading to cGMP production and antagonizing hypertrophy, 16, 17 although activation of PI-3Ka through direct interaction with estrogen receptor is another possible activation mechanism. 18, 19 Although the role of Akt in establishing physiological hypertrophy is well known, whether it has an anti-apoptotic effect also during this condition needs further investigation.
